The Japanese Journal of Antibiotics
Online ISSN : 2186-5477
Print ISSN : 0368-2781
ISSN-L : 0368-2781
STUDIES OF ISOLATED ORGANISMS FROM OTORHINOLARYNGOLOGICAL INFECTIONS AND THEIR SUSCEPTIBILITIES TO MACROLIDE ANTIBIOTICS
BUEMON SANBEHARUJI KINOSHITAHIDEAKI SUZUKIHIROKAZU SHIBUIHIROYUKI ZUSHOJUN KAWAKUBOJUNICHIRO SHIMADAKENJI SUZUKIKOHZO FUKAMIKOICHI DEGUCHIKUNIHIKO SAKAMOTOMASARU OHYAMANORIKO YAHATARINYA SUGITASHIGEKAZU TSUBAKISHOZO KAWAMURASHUJI OGURASHUNKICHI BABATSUNEMASA SATOYASUICHI OHORIYOSHITO MORIYUTAKA FUJIMAKI
Author information
JOURNAL FREE ACCESS

1985 Volume 38 Issue 5 Pages 1355-1367

Details
Abstract
To study current situation of pathogenic bacteria and their drug resistance to macrolide antibiotics in the otorhinolaryngological infections, 609 strains diagnosed as pathogen derived from 463 patients were collected from cohospitals or institutions during the period of 1980-1983.
The results obtained were as follows:
1. Gram-positive cocci (GPC) was dominant (410 strains) and major species wereS. aureus (135 strains), S. pneumoniae (81 strains), S. epidermidis (68 strains) and S. pyogenes (65 strains). In Gram-negative bacteria giving 147 strains and 43 strains, of anaerobes prevailing species were H. influenzae, P. aeruginosa andPeptostreptococcus spp.
2. Representative species in the diseases were S. aureus (26.6%), S. epidermidis (24.5%), and P. aeruginosa (12.8%) in acute otitis media, S. aureus (34.4%), S. epidermidis (17.7%) and P. aeruginosa (14.6%) in acute exacerbation of chronic otitis media, S. epidermidis (17.0%), S. aureus (16.1%) and H. influenzae (13.4%) in acute paranasal sinusitis, S. pyogenes (29.1%), S. pneumoniae (19.6%) and S. aureus (15.1%) in acute tonsillitis.
3. Although most of isolates were susceptible to macrolides, 62 resistant strains to macrolides were found in 501 strains and the resistant rates were 26.7% in S. aureus, 23.1% in S. epidermidis and 6.5% in S. pyogenes. The resistant pattern was somewhat different against each macrolides, resistant strains giving over 100μg/ml in MIC were 55/62 in erythromycin, 35/62 in josamycin and midecamycin and 7/62 in TMS-19-Q, a new macrolide.
Content from these authors
© Japan Antibiotics Research Association
Previous article Next article
feedback
Top